EU's neutron medtech R&D centre a step closer - UPDATE
This article was originally published in Clinica
Executive Summary
The European Spallation Source (ESS), set to become a world-leading centre of neutron-based atomic and molecular imaging and biomaterials R&D, should be built in Lund, Sweden, EU ministers have said. The €1.3bn ($1.8bn) ESS – details of its funding have yet to be agreed – will rival the world's only other two centres, in Japan and the US, as "the world's most important source of neutrons".